Katarzyna Petru
Samsung Medison attracted the attention of the medical community during the ISUOG 2025 congress in Cancún, presenting a new generation of ultrasound solutions dedicated to women's health – from the fetal period, through pregnancy and menopause, to care for elderly patients.
HERA Z20 – one device for every stage of a woman's life
The most significant launch was the improved HERA Z20 platform, showcased under the tagline "From Challenges to Solutions: Experience the Innovation". It is equipment designed to support doctors in managing patients at every stage – from gynaecological issues in teenagers and infertility treatment, to diagnostics during pregnancy and menopause.
Among the new features is PelvicAssist™, which automatically analyses pelvic structures and calculates the area of the pelvic floor muscle hiatus in 3D. Additionally, Samsung has included three reporting modules that comply with international clinical guidelines: Fibroid 2D (for uterine fibroids according to FIGO), IDEA (for endometriosis), and IETA (for endometrial tumours). All these enhancements aim to shorten examination times and facilitate the description of complex cases for doctors.
An interesting addition is also the Mini ER7 – a probe with a head that is 63% smaller than traditional ones, designed with the comfort of patients in mind, especially young girls and elderly individuals.
New features for high-risk pregnancies
The increasing age of mothers means that doctors are more frequently encountering pregnancies with risks. Samsung is responding to this trend by adding to the system, among other things, the examination of the Ophthalmic Artery – allowing for early detection of symptoms of pre-eclampsia and monitoring the risk of cardiovascular disorders.
The enhanced HeartAssist™ feature allows for continuous assessment of heart function during pregnancy, while Live ViewAssist™ automatically generates up to 39 ultrasound scans, adding descriptions and measurements in real-time. This significantly shortens diagnostic time and alleviates the workload on doctors.
Completing this is QualityCheck, a tool that automatically assesses the quality of images during prenatal examinations – ensuring repeatability and accuracy of diagnosis.
AI Supports Doctors
– “The new HERA Z20 is not just an equipment upgrade, but a comprehensive solution for women's health. By combining artificial intelligence with the clinical experience of specialists, we aim to increase diagnostic accuracy and ease the burden on doctors, which could realistically change healthcare in the long run” – emphasised Jihyun Kim, head of the CX department at Samsung Medison.
In practice, this means that AI-based modules are not just a marketing add-on, but real support in everyday work. Algorithms analyse ultrasound images in the background, automate measurements, suggest key parameters, and recommend guideline-compliant ways of reporting. As a result, doctors can focus on interpreting results and conversing with the patient, rather than wasting time on tedious descriptions of sections or calculations.
In prenatal examinations, where every minute and every millimetre counts, such automation can be crucial. Moreover, consistent report templates compliant with FIGO, IDEA, or IETA standardise the quality – a patient at a large diagnostic centre and at a smaller facility receives a report that adheres to the same international guidelines.
AI also has enormous educational potential – less experienced specialists learn faster by observing how the system suggests interpretations of subtle changes that are obvious to an expert. In this sense, the HERA Z20 can be called a “comprehensive solution”: equipment that not only improves image quality but also changes the working model, increases efficiency, and allows for more predictable treatment outcomes.
